ECSP034579A - Combinacion de formulaciones adyuvantes - Google Patents

Combinacion de formulaciones adyuvantes

Info

Publication number
ECSP034579A
ECSP034579A ECSP034579A ECSP034579A EC SP034579 A ECSP034579 A EC SP034579A EC SP034579 A ECSP034579 A EC SP034579A EC SP034579 A ECSP034579 A EC SP034579A
Authority
EC
Ecuador
Prior art keywords
combination
formulations
adjustment
glucosaline
granulite
Prior art date
Application number
Other languages
English (en)
Inventor
Michael Hagen
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of ECSP034579A publication Critical patent/ECSP034579A/es

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Este invento se refiere al uso de un compuesto de aminoalquilo glucosalina fosfato o un derivado o análogo del mismo, en combinación con una linfoquina, en particular un factor estimulante de la colonia de granulcito macrófago o interleuquin-12, como formulación adyuvante en una composición antígenico o inmunogénico para mejorar la respuesta inmunológico de un huésped vertebrado a un antígeno seleccionado.
ECSP034579 2000-11-10 2003-05-08 Combinacion de formulaciones adyuvantes ECSP034579A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US24710000P 2000-11-10 2000-11-10

Publications (1)

Publication Number Publication Date
ECSP034579A true ECSP034579A (es) 2003-08-29

Family

ID=34115118

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP034579 ECSP034579A (es) 2000-11-10 2003-05-08 Combinacion de formulaciones adyuvantes

Country Status (5)

Country Link
AR (1) AR031211A1 (es)
EC (1) ECSP034579A (es)
MY (1) MY142635A (es)
SA (1) SA02230071B1 (es)
ZA (1) ZA200304479B (es)

Also Published As

Publication number Publication date
AR031211A1 (es) 2003-09-10
MY142635A (en) 2010-12-15
ZA200304479B (en) 2004-09-09
SA02230071B1 (ar) 2008-11-17

Similar Documents

Publication Publication Date Title
PT2364724E (pt) Composição de vacina compreendendo um adjuvante de saponina
NO20005051L (no) Adjuvantsammensetninger
DK1187629T3 (da) Adjuvanssammensætning omfattende saponin og et immunostimulerende oligonucleotid
FR2781159B1 (fr) Vaccin circovirus et parvovirus porcin
CY1112698T1 (el) Ανοσογονος συνθεση
CR7776A (es) Conjugados de polimero con antigenicidad disminuida, metodos de preparacion y usos de los mismos
LU91778I2 (fr) Menveo - vaccin méningococcique des groupes A,C, W135 et Y conjugué.
ATE501726T1 (de) Zusammensetzung mit immunogenen mikroteilchen
EP2275122A3 (en) Protein-based streptococcus pneumoniae vaccines
DK1259259T3 (da) Mucosal adjuvansformulering
UY26297A1 (es) Vacuna
IS6156A (is) Samsettar ónæmisglæðablöndur
IL162692A (en) Aqueous based pharmaceutical formulations of water-soluble prodrugs of propofol
WO2002053176A3 (en) An autologous anti-cancer vaccine
ECSP034579A (es) Combinacion de formulaciones adyuvantes
EP1905449A3 (en) Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide
EA200300557A1 (ru) Комбинированные композиции адъювантов
UY27016A1 (es) Formulaciones de combinación de adyuvantes
AU7960101A (en) Parenteral vaccine formulations and uses thereof
AU6761301A (en) Adjuvant composition comprising fha protein or fragment of fha protein in free form
DK1401492T3 (da) LTB4 som vaccineadjuvans